Healthcare Sales & Marketing Network News: Cesamet

Searching News Database: Cesamet

HSMN NewsFeed - 4 Aug 2008
Meda Acquires European Businesses from American Valeant and Enters the Russian Market
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Feb 2007
Valeant Pharmaceuticals Files Investigational New Drug Application for Cesamet(R) in Cancer Chemotherapy-Induced Neuropathic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Feb 2007
Valeant Pharmaceuticals Acquires Rights to Nabilone in United Kingdom and Europe
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2007
NCCN Updates Antiemesis Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Nov 2006
Par Announces Termination of Cesamet(TM) Promotion Agreement
Biopharmaceuticals

HSMN NewsFeed - 17 Aug 2006
Valeant Pharmaceuticals Announces U.S. Availability of Cesamet(TM) (CII) and Initiates Post-Marketing Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 16 May 2006
Valeant Pharmaceuticals Receives FDA Marketing Approval for Cannabinoid Cesamet(TM) (CII)
Biopharmaceuticals FDA

Return to NewsFeed

Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 3 additional stories matching:
Cesamet
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.